DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20184022

Biowarfare: Where do we stand?

Kalpita S. Shringarpure, Keyur Brahme

Abstract


Use of biological weapons has dated since times immemorial and the fear of such weapons in sync with the ever growing technology looms large on every part of the world. Biological warfare dates long back, when Hannibal first used the ‘serpents’ in earthen pots to be hurled against the enemy to sophisticated Biowarfare weapons such as Bacillus anthracis and Pseudomonas pseudomallei. To prohibit the use of such biological weapons, international treaties were prepared in 1925 and 1972; but to no avail. Many nations have stocked biological warfare agents, and there is possibility that terrorists may acquire the expertise to use these destructive agents. Advantages of Biowarfare agents are that they are produced rapidly, are cost-effective, can disseminate and affect a large area leading to high morbidity and mortality. With the upsurge in chances of biological warfare being used for defense or terrorism, there is a need for a robust surveillance system involving the health care sector along with integration of public health personnel, security, intelligence, diplomats and law enforcement agencies. Thus for the world, the time has come to establish a mindset to wage a war against this Biowarfare, try to discover newer antibiotics and personal protective equipment, acquire ‘state-of-the-art’ detectors and focus on the available intelligence. Awareness among the public, clinicians and public health experts, stock piling of drugs and vaccines, allocation of funds and Biowarfare preparedness is the need of the day.


Keywords


Bioterrorism, Warfare, Biowarfare preparedness

Full Text:

PDF

References


Eitzen EM, Takafuji ET. Historical overview of biological warfare. Chapter 18. 1997;994:415–23.

Frischknecht F. The History of Biological Warfare. 2008: 1–10.

Dasilva EJ. Biowarfare and bioterrorism - The dark side of biotechnology. Biotechnology. Vol XIV.

Richard P. The Cobra Event. Available from: http://richardpreston.net/preston-books/the-cobra-event

Alibek K, Handelman S. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World: Told from the inside by the Man Who Ran It. Foreign Aff. 1999;268.

Agarwal R, Shukla SK, Dharmani S, Gandhi A. Biological Warfare — An Emerging Threat. 2004;52:733–8.

Oxford University Press; 1986. Available at: https://global.oup.com/academic/product/sipri-yearbook-1986-9780198291008. Accessed on 2 June 2018.

Medical Management of Biological Casualties Handbook. 2nd ed. US Army Medical Research Institute of Infectious Diseases; 1996.

Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266(5188):1202–8.

United Nations. Distr. General S/1995/1038; 1995.

Biological Warfare Causes, Symptoms, Treatment - Plague – eMedicine Health. Available at: www.emedicinehealth.com/home/infectionscenter/infections az list.

Sharma R. India wakes up to the threat of bioterrorism. BMJ. 2001;323(7315):714.

Biological weapon - Wikipedia, the Biological warfare as translated, the free encyclopedia. Available at: https://en.wikipedia.org/wiki/ Biological_warfare. Accessed on 3 June 2018.

Christian MD. Biowarfare and Bioterrorism. Crit Care Clin. 2013;29(3):717–56.

Treadwell TA, Koo D, Kuker K, Khan AS. Epidemiologic clues to bioterrorism. Public Health Rep. 2003;118(2):92–8.

Moving Toward Information in the Blink of an Eye; 2010:2010.

Encoded metallic nanowires reveal bioweapons _ EurekAlert! Science News. Available at: www.eurekalert.org/pub_releases/2006-08/jws-emn081006.php. Accessed on 2 June 2018.

BioPen Senses BioThreats _ TFOT. Available at: thefutureofthings.com/3039-biopen-senses-biothreats. Accessed on 2 June 2018.

Kelle A. Ensuring the security of synthetic biology-towards a 5p governance strategy. Syst Synth Biol. 2009;3(1):85–90.

Garfinkel MS, Endy D, Epstein GL, Friedman RM. Synthetic genomics: Options for governance. Biosecur Bioterror. 2007;5(4):359–62.

National Science Advisory Board for Biosecurity. Addressing Biosecurity Concerns Related to Synthetic Biology. 2010. Available at: http://osp.od. nih.gov/sites/default/files/resources/One%20Page%20Summary%20of%20NSABB%20Reports_Updated.pdf. Accessed on 2 June 2018.

Ainscough MJ. Next Generation Bioweapons. Counterproliferation Pap Ser. 2002: 14.

Cello J, Paul A V, Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science. 2002;297(5583):1016–8.

Wimmer E, Mueller S, Tumpey TM, Taubenberger JK. Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat Biotechnol. 2010;27(12):1–23.

Pinto VN. Bioterrorism: Health sector alertness. J Nat Sci Biol Med. 2013;4(1):24–8.

Suryakantha AH editor. Community Medicine (with resent advances) 1st ed. New Delhi: Jaypee Publishers; 2009: 822–4.

Lederberg J. Biological Weapons: Limiting the Threat. MIT Press. 1999;19:351.